Israel delays tourism in bid to douse Covid-19 variant upsurge straitstimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from straitstimes.com Daily Mail and Mail on Sunday newspapers.
Covid-19: Vaccine as good in real world as in trial in Israel
By Rachel Schraer
More data from Israel s vaccination programme is suggesting the Pfizer jab prevents 94% of symptomatic infections.
This indicates the vaccine is performing just as well in a larger population as it did in the clinical trials.
It is proving highly effective at preventing illness and severe disease among all age groups, according to public health doctor Prof Hagai Levine. High vaccination coverage of the most susceptible groups was key, he said.
Israel s largest health fund Clalit looked at positive tests in 600,000 vaccinated people and the same number of unvaccinated people, matched by age and health status.
vaccine prevents 94% of symptomatic infections.
This indicates the
vaccine is performing just as well in a larger population as it did in the clinical trials.
It is proving highly effective at preventing illness and severe disease among all age groups, according to public health doctor Prof Hagai Levine.
Israel s largest health fund Clalit looked at positive tests in 600,000 vaccinated people and the same number of unvaccinated people, matched by age and health status.
It found 94% fewer infections among the vaccinated group.
This was based on test results in people s medical records, usually taken if they had symptoms or were a close contact of someone who had tested positive.
Since Israel began administering the second dose on January 10, there has been a 30 per cent drop in hospitalisations in over-60s and a 20 per cent decline in those falling seriously ill with Covid.